4796 related articles for article (PubMed ID: 3159801)
21. Nevomelanocytic atypia detection by in vivo reflectance confocal microscopy.
Vaišnorienė I; Rotomskis R; Kulvietis V; Eidukevičius R; Zalgevičienė V; Laurinavičienė A; Venius J; Didžiapetrienė J
Medicina (Kaunas); 2014; 50(4):209-15. PubMed ID: 25458957
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical characterization of seminoma and its inflammatory cell infiltrate.
Bell DA; Flotte TJ; Bhan AK
Hum Pathol; 1987 May; 18(5):511-20. PubMed ID: 3552955
[TBL] [Abstract][Full Text] [Related]
23. Interferon-gamma regulates the T cell response to precursor nevi and biologically early melanoma.
Guerry D; Alexander MA; Elder DE; Herlyn MF
J Immunol; 1987 Jul; 139(1):305-12. PubMed ID: 3108402
[TBL] [Abstract][Full Text] [Related]
24. Presence of activated lymphocytes in the peripheral blood of patients with halo nevi.
Baranda L; Torres-Alvarez B; Moncada B; Portales-Pérez D; de la Fuente H; Layseca E; González-Amaro R
J Am Acad Dermatol; 1999 Oct; 41(4):567-72. PubMed ID: 10495377
[TBL] [Abstract][Full Text] [Related]
25. An absence of human leukocyte antigen-DR and a decreased expression of beta 2-microglobulin on tumor cells of basal cell carcinoma: no influence on the peritumoral immune infiltrate.
Habets JM; Tank B; Vuzevski VD; Stolz E; van Joost T
J Am Acad Dermatol; 1989 Jan; 20(1):47-52. PubMed ID: 2521495
[TBL] [Abstract][Full Text] [Related]
26. Melanocyte-specific immune response in a patient with multiple regressing nevi and a history of melanoma.
Speeckaert R; van Geel N; Luiten RM; van Gele M; Speeckaert M; Lambert J; Vermaelen K; Tjin EP; Brochez L
Anticancer Res; 2011 Nov; 31(11):3697-703. PubMed ID: 22110189
[TBL] [Abstract][Full Text] [Related]
27. The immunopathology of regression in benign lichenoid keratosis, keratoacanthoma and halo nevus.
Bayer-Garner IB; Ivan D; Schwartz MR; Tschen JA
Clin Med Res; 2004 May; 2(2):89-97. PubMed ID: 15931341
[TBL] [Abstract][Full Text] [Related]
28. Expression of HLA ABC and DR antigens in thyroid neoplasia and correlation with mononuclear leukocyte infiltration.
Fisfalen ME; Franklin WA; DeGroot LJ; Cajulis RS; Soltani K; Ryan M; Jones N
J Endocrinol Invest; 1990 Jan; 13(1):41-8. PubMed ID: 2181018
[TBL] [Abstract][Full Text] [Related]
29. Granulomatous inflammation in nevi undergoing regression (halo phenomenon): a report of 6 cases.
Denianke KS; Gottlieb GJ
Am J Dermatopathol; 2008 Jun; 30(3):233-5. PubMed ID: 18496423
[TBL] [Abstract][Full Text] [Related]
30. Human monoclonal antibodies that distinguish cutaneous malignant melanomas from benign nevi in fixed tissue sections.
Imam A; Mitchell MS; Modlin RL; Taylor CR; Kempf RA; Kan-Mitchell J
J Invest Dermatol; 1986 Feb; 86(2):145-8. PubMed ID: 3528308
[TBL] [Abstract][Full Text] [Related]
31. Reduced ecto-5'-nucleotidase activity and enhanced OKT10 and HLA-DR expression on CD8 (T suppressor/cytotoxic) lymphocytes in the acquired immune deficiency syndrome: evidence of CD8 cell immaturity.
Salazar-Gonzalez JF; Moody DJ; Giorgi JV; Martinez-Maza O; Mitsuyasu RT; Fahey JL
J Immunol; 1985 Sep; 135(3):1778-85. PubMed ID: 2991373
[TBL] [Abstract][Full Text] [Related]
32. Phenotypic dynamics of tumor progression in human malignant melanoma.
Bröcker EB; Suter L; Brüggen J; Ruiter DJ; Macher E; Sorg C
Int J Cancer; 1985 Jul; 36(1):29-35. PubMed ID: 3860479
[TBL] [Abstract][Full Text] [Related]
33. HCV infection, hepatic HLA display and composition of the mononuclear cell inflammatory infiltrate in chronic alcoholic liver disease.
Freni MA; Ajello A; Resta ML; Gaeta GB; Spadaro A; Fava A; Calapristi I; Alessi N; Ferraù O
Eur J Clin Invest; 1991 Dec; 21(6):586-91. PubMed ID: 1723384
[TBL] [Abstract][Full Text] [Related]
34. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis.
Bottazzo GF; Dean BM; McNally JM; MacKay EH; Swift PG; Gamble DR
N Engl J Med; 1985 Aug; 313(6):353-60. PubMed ID: 3159965
[TBL] [Abstract][Full Text] [Related]
35. Foxp3(+) regulatory T cells are increased in the early stages of halo nevi: clinicopathological features of 30 halo nevi.
Park HS; Jin SA; Choi YD; Shin MH; Lee SE; Yun SJ
Dermatology; 2012; 225(2):172-8. PubMed ID: 23006793
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical characterization of tumor cells and inflammatory infiltrate associated with cutaneous melanocytic tumors of Duroc and Iberian swine.
Perez J; García PM; Bautista MJ; Millán Y; Ordás J; Martín de las Mulas J
Vet Pathol; 2002 Jul; 39(4):445-51. PubMed ID: 12126147
[TBL] [Abstract][Full Text] [Related]
37. Monoclonal antibody (AFH1) immunoreactive on morphologically abnormal basal melanocytes within dysplastic nevi, nevocellular nevus nests, and melanoma.
Aronson PJ; Ito K; Fukaya T; Hashimoto K; Mehregan AH
J Invest Dermatol; 1988 Apr; 90(4):452-8. PubMed ID: 3280697
[TBL] [Abstract][Full Text] [Related]
38. Fibrosis in regressing melanoma versus nonfibrosis in halo nevus upon melanocyte disappearance: could it be related to a different cytokine microenvironment?
Moretti S; Spallanzani A; Pinzi C; Prignano F; Fabbri P
J Cutan Pathol; 2007 Apr; 34(4):301-8. PubMed ID: 17381800
[TBL] [Abstract][Full Text] [Related]
39. HLA typing using IL-2 activated T lymphocytes: usefulness in pediatric candidates for allogeneic bone marrow transplantation.
Kubo K; Tachino J; Ichikawa S; Hamamoto K; Ueda K
Bone Marrow Transplant; 1991 Sep; 8(3):185-90. PubMed ID: 1720338
[TBL] [Abstract][Full Text] [Related]
40. Expression of major histocompatibility antigens and leucocyte infiltration in benign and malignant human breast disease.
Whitwell HL; Hughes HP; Moore M; Ahmed A
Br J Cancer; 1984 Feb; 49(2):161-72. PubMed ID: 6365133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
